955992

Bell Pharmaceuticals, Inc — FEI 2123499

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Belle Plaine, MN (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
141821 CFR 211.42(c)(7)Quarantined Drug Products Area
150521 CFR 211.122(d)Label storage access limited to authorized personnel
200921 CFR 211.188Prepared for each batch, include complete information